X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1091) 1091
Publication (300) 300
Book Review (8) 8
Book Chapter (5) 5
Conference Proceeding (3) 3
Dissertation (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (771) 771
animals (670) 670
index medicus (579) 579
mice (444) 444
neurofibromin 2 - metabolism (304) 304
cell biology (290) 290
neurofibromin 1 - genetics (288) 288
biochemistry & molecular biology (275) 275
neurofibromin 1 - metabolism (252) 252
mutation (238) 238
neurofibromin 2 - genetics (225) 225
signal transduction (216) 216
oncology (202) 202
merlin (201) 201
female (200) 200
male (192) 192
article (189) 189
expression (189) 189
neurofibromatosis (186) 186
genetics & heredity (168) 168
phosphorylation (167) 167
neurofibromin 2 (165) 165
neurofibromin 1 (156) 156
nf1 (154) 154
congenital, hereditary, and neonatal diseases and abnormalities (150) 150
cells, cultured (147) 147
tumors (146) 146
neurofibromatosis 1 - genetics (139) 139
cancer (137) 137
cell proliferation (134) 134
cell line, tumor (133) 133
nervous system diseases (133) 133
proteins (131) 131
neurosciences (129) 129
growth (125) 125
molecular sequence data (123) 123
research (114) 114
membrane proteins - metabolism (113) 113
gene expression (112) 112
genetic aspects (112) 112
immunohistochemistry (110) 110
mice, knockout (106) 106
tumor-suppressor (106) 106
neurofibromin (105) 105
gene (99) 99
protein binding (99) 99
neurofibromatosis 1 - metabolism (98) 98
neoplasms (96) 96
mutations (95) 95
activation (94) 94
analysis (94) 94
gene-product (94) 94
multidisciplinary sciences (93) 93
ras (93) 93
cells (92) 92
protein (91) 91
amino acid sequence (90) 90
disease models, animal (90) 90
cell line (89) 89
rats (88) 88
adult (87) 87
mice, inbred c57bl (87) 87
ras proteins - metabolism (87) 87
neurofibromatosis type-2 (84) 84
nf2 (83) 83
schwann cells - metabolism (81) 81
neurofibromatosis 1 - pathology (78) 78
membrane proteins - genetics (77) 77
mice, transgenic (77) 77
research article (77) 77
proliferation (76) 76
base sequence (75) 75
blotting, western (75) 75
developmental biology (74) 74
middle aged (73) 73
transfection (72) 72
apoptosis (70) 70
pathology (70) 70
phenotype (70) 70
schwann-cells (69) 69
tumor cells, cultured (69) 69
gene expression regulation, neoplastic (68) 68
ezrin (66) 66
identification (66) 66
nf2 tumor-suppressor (66) 66
phosphoproteins - metabolism (66) 66
protein-serine-threonine kinases - metabolism (66) 66
biology (65) 65
clinical neurology (65) 65
protein structure, tertiary (64) 64
kinases (63) 63
neurilemmoma - metabolism (63) 63
neurofibromin 1 - deficiency (63) 63
signal transduction - physiology (63) 63
nf2 gene (62) 62
physiological aspects (62) 62
neurofibromatosis type-1 (61) 61
medicine (60) 60
neurofibromatosis type 1 (60) 60
binding sites (58) 58
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
Journal of Cell Biology, ISSN 0021-9525, 2017, Volume 216, Issue 2, pp. 495 - 510
Loss of the Merlin tumor suppressor and activation of the Hippo signaling pathway play major roles in the control of cell proliferation and tumorigenesis. We... 
MYELIN | PERIPHERAL-NERVES | ORGAN SIZE CONTROL | SIGNALING PATHWAY | REGENERATION | TISSUE HOMEOSTASIS | MONOCYTE CHEMOATTRACTANT PROTEIN-1 | YAP | C-JUN | NEGATIVE REGULATOR | CELL BIOLOGY | Neurofibromin 2 - genetics | Sciatic Nerve - injuries | Cell Proliferation | Male | Sciatic Nerve - physiopathology | Crush Injuries - genetics | Nerve Growth Factors - metabolism | Motor Activity | Phosphoproteins - metabolism | Recovery of Function | Myelin Sheath - metabolism | Sciatic Nerve - metabolism | Sciatic Neuropathy - genetics | Time Factors | Neurofibromin 2 - deficiency | Female | Crush Injuries - pathology | Neurofibromin 2 - metabolism | Protein-Serine-Threonine Kinases - metabolism | Disease Models, Animal | Signal Transduction | Sciatic Nerve - pathology | Axons - metabolism | Sciatic Neuropathy - pathology | Genotype | Schwann Cells - pathology | Schwann Cells - metabolism | Crush Injuries - physiopathology | Nerve Regeneration | Phosphoproteins - genetics | Mice, Knockout | Crush Injuries - metabolism | Phenotype | Animals | Neuronal Plasticity | Proto-Oncogene Proteins c-jun - metabolism | Adaptor Proteins, Signal Transducing - deficiency | Axons - pathology | Phosphoproteins - deficiency | Adaptor Proteins, Signal Transducing - genetics | Sciatic Neuropathy - physiopathology | Adaptor Proteins, Signal Transducing - metabolism | Sciatic Neuropathy - metabolism | Mitogen-Activated Protein Kinases - metabolism
Journal Article
Oncogene, ISSN 0950-9232, 04/2013, Volume 32, Issue 14, pp. 1821 - 1830
The Salvador/Warts/Hippo (Hippo) signaling pathway defines a novel signaling cascade regulating cell contact inhibition, organ size control, cell growth,... 
KIBRA | Willin | breast cancer | Hippo pathway | Merlin | claudin-low | APOPTOSIS | PROTEIN | ORGAN SIZE CONTROL | BIOCHEMISTRY & MOLECULAR BIOLOGY | YAP | PROLIFERATION | DROSOPHILA | CELL BIOLOGY | EPITHELIAL-MESENCHYMAL TRANSITION | BREAST-CANCER CELLS | ONCOGENE | ONCOLOGY | CYCLE EXIT | GENETICS & HEREDITY | RNA, Small Interfering - genetics | Neurofibromin 2 - genetics | Cell Proliferation | Oligonucleotide Array Sequence Analysis | Cytoskeletal Proteins - genetics | Humans | Gene Expression Profiling | Intracellular Signaling Peptides and Proteins - metabolism | Immunoenzyme Techniques | Hepatocyte Growth Factor - antagonists & inhibitors | Biomarkers, Tumor - metabolism | Hepatocyte Growth Factor - genetics | Carcinoma, Ductal, Breast - pathology | Carcinoma, Ductal, Breast - metabolism | Intracellular Signaling Peptides and Proteins - genetics | Real-Time Polymerase Chain Reaction | Protein-Serine-Threonine Kinases - metabolism | Signal Transduction | Breast - cytology | Membrane Proteins - genetics | Reverse Transcriptase Polymerase Chain Reaction | Cell Adhesion | Blotting, Western | Hepatocyte Growth Factor - metabolism | Breast Neoplasms - genetics | Claudin-1 - genetics | Biomarkers, Tumor - genetics | Cell Movement | Carcinoma, Ductal, Breast - genetics | Phosphorylation | Phosphoproteins - antagonists & inhibitors | Phosphoproteins - metabolism | Breast - metabolism | Breast Neoplasms - metabolism | Claudin-1 - metabolism | Epithelial-Mesenchymal Transition | Protein-Serine-Threonine Kinases - antagonists & inhibitors | Cytoskeletal Proteins - metabolism | Female | Membrane Proteins - metabolism | Nuclear Proteins - genetics | Neurofibromin 2 - metabolism | Proto-Oncogene Proteins - metabolism | Proto-Oncogene Proteins - antagonists & inhibitors | Intracellular Signaling Peptides and Proteins - antagonists & inhibitors | RNA, Messenger - genetics | Cells, Cultured | Protein-Serine-Threonine Kinases - genetics | Nuclear Proteins - metabolism | Proto-Oncogene Proteins - genetics | Transcription Factors - antagonists & inhibitors | Phosphoproteins - genetics | Transcription Factors - genetics | Transcription Factors - metabolism | Breast Neoplasms - pathology | Nuclear Proteins - antagonists & inhibitors | Apoptosis | Cellular proteins | Prognosis | Physiological aspects | Breast cancer | Genetic aspects | Cellular signal transduction | Research | Health aspects | Mammals | Gene expression
Journal Article
Nature, ISSN 0028-0836, 2014, Volume 514, Issue 7521, pp. 247 - 251
The polycomb repressive complex 2 (PRC2) exerts oncogenic effects in many tumour types(1). However, loss-of-function mutations in PRC2 components occur in a... 
SUPPRESSOR | GENE | MULTIDISCIPLINARY SCIENCES | MICE | NF1 MICRODELETION PATIENTS | MUTATIONS | BET BROMODOMAIN INHIBITION | CANCER | TUMORS | NEUROFIBROMATOSIS TYPE-1 | EZH2 | Chromatin - metabolism | Transcription, Genetic - drug effects | Polycomb Repressive Complex 2 - genetics | Humans | Transcription Factors - deficiency | ras Proteins - metabolism | Neurofibromin 1 - deficiency | Glioma - genetics | Neoplasms - genetics | Melanoma - genetics | Tumor Suppressor Proteins - deficiency | Glioma - pathology | Nerve Sheath Neoplasms - pathology | Nuclear Proteins - deficiency | Tumor Suppressor Proteins - genetics | Epigenesis, Genetic - drug effects | Cell Death - drug effects | Gene Expression Regulation, Neoplastic - drug effects | Nuclear Proteins - genetics | Chromatin - drug effects | Nerve Sheath Neoplasms - drug therapy | Disease Models, Animal | Triazoles - therapeutic use | Nerve Sheath Neoplasms - genetics | Tumor Suppressor Proteins - metabolism | Mitogen-Activated Protein Kinase Kinases - antagonists & inhibitors | ras Proteins - antagonists & inhibitors | Nuclear Proteins - metabolism | Transcription Factors - antagonists & inhibitors | Melanoma - pathology | Transcription Factors - genetics | Azepines - therapeutic use | Neoplasms - drug therapy | Azepines - pharmacology | Transcription Factors - metabolism | Triazoles - pharmacology | Animals | Polycomb Repressive Complex 2 - deficiency | Melanoma - drug therapy | Nuclear Proteins - antagonists & inhibitors | Mice | Neoplasms - pathology | Polycomb Repressive Complex 2 - metabolism | Chromatin - genetics | Neurofibromin 1 - genetics | Glioma - drug therapy | Epigenetic inheritance | Ras genes | Genetic transcription | Research | Gliomas | Studies | Mutation | Genes | Tumors | Defects
Journal Article
Genes and Development, ISSN 0890-9369, 06/2015, Volume 29, Issue 12, pp. 1271 - 1284
Journal Article
Cancer Research, ISSN 0008-5472, 09/2017, Volume 77, Issue 18, pp. 5026 - 5038
Neurofibromatosis type 2 (NF2) is an autosomal dominant disorder characterized by the development of multiple tumors in the central nervous system, most... 
Fatty Acid Synthase, Type I - genetics | Neurofibromin 2 - genetics | Cell Proliferation | TOR Serine-Threonine Kinases - metabolism | Humans | Multiprotein Complexes - genetics | Meningioma - genetics | Embryo, Mammalian - metabolism | Mechanistic Target of Rapamycin Complex 1 | Multiprotein Complexes - metabolism | TOR Serine-Threonine Kinases - genetics | Neurilemmoma - genetics | Biomarkers, Tumor - metabolism | Female | Lipogenesis | Fatty Acids - metabolism | Neurofibromin 2 - metabolism | Fibroblasts - metabolism | Meningeal Neoplasms - genetics | Meningioma - metabolism | Cells, Cultured | Rats | Survival Rate | Fatty Acid Synthase, Type I - metabolism | Neurilemmoma - pathology | Xenograft Model Antitumor Assays | Meningioma - pathology | Animals | Neurilemmoma - metabolism | Embryo, Mammalian - cytology | Mice, Nude | Biomarkers, Tumor - genetics | Fibroblasts - cytology | Meningeal Neoplasms - metabolism | Mice | Meningeal Neoplasms - pathology | Apoptosis | Deactivation | Central nervous system | Schwann cells | Neurofibromin 2 | Neurofibromatosis 2 | Metabolism | Palmitic acid | Inactivation | Fatty acids | Fatty-acid synthase | Hereditary diseases | Molecular modelling | Inhibitors | Neurofibromatosis | Tumor suppressor genes | Lipid metabolism | Mutation | Tumors | Cancer | small molecule inhibitors | metabolism | fatty acid synthesis | neurofibromatosis 2 | schwannoma
Journal Article
Journal Article
Journal Article